Back to top
more

CVS Health (CVS)

(Real Time Quote from BATS)

$59.72 USD

59.72
9,483,857

+0.12 (0.20%)

Updated Jun 3, 2024 12:52 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth F Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 4% (239 out of 250)

Industry: Retail - Pharmacies and Drug Stores

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.

Walgreens (WBA) May Buy Remaining Stake in AmerisourceBergen

by Zacks Equity Research

Walgreens' (WBA) rumored buyout claim over the remaining stake in AmerisourceBergen comes close on the heels of its rival CVS Health's hefty $69-billion worth acquisition of health insurer, Aetna.

    Top Analyst Reports for Broadcom, Canadian National & CVS Health

    by Zacks Equity Research

    Today's Research Daily features new research reports on 16 major stocks, including Broadcom (AVGO), Canadian National (CNI) and CVS Health (CVS).

      CVS Health (CVS) Beats On Q4 Earnings & Revenues Estimates

      by Zacks Equity Research

      CVS Health (CVS) rides high on strength in Pharmacy Services segment in Q4.

        Health Insurance Stock Outlook - January 2018

        by Zacks Equity Research

        Rapid evolution is being witnessed in the health insurance industry as the players are taking concerted efforts to transform themselves into comprehensive health care providers from their earlier role of traditional payers.

          Fred's (FRED) Sluggish Store Sales Keep Investors at Bay

          by Zacks Equity Research

          Fred's (FRED) continues to witness dismal comps and store closures. Also, cancelled dividend and merger deal make this retailer a less-favored pick.

            5 Reasons Why McKesson Deserves a Place in Your Portfolio

            by Zacks Equity Research

            McKesson (MCK) continues to pursue deals, divestitures and acquisitions to drive growth. The company's impressive performance in 2017 accounts for its potential to sustain the momentum.

              Company News For January 5, 2018

              by Zacks Equity Research

              Companies In The News are:

                CVS Health's (CVS) Outlook for 2018 Cheered by Investors

                by Zacks Equity Research

                CVS Health (CVS) to witness increased cash flow of around $1.2 billion in 2018, courtesy the latest US Tax legislation.

                  Fred's Tanks 79% in a Year: Any Chances of Revival Ahead?

                  by Zacks Equity Research

                  Fred's (FRED) has been struggling with its dismal comps performance stemming from receding traffic and store closures. Also, management cancelled its quarterly dividend recently.

                    Declining Comps Likely to Hurt Fred's (FRED) in Q3 Earnings

                    by Zacks Equity Research

                    Fred's (FRED) third-quarter fiscal 2017 performance is expected to be hurt by dismal comps trend.

                      Company News For Nov 7, 2017

                      by Zacks Equity Research

                      Companies In The News are: ON,BRK.B,S,TMUS,CVS

                        McKesson (MCK) to Acquire RxCrossroads for $735 Million

                        by Zacks Equity Research

                        McKesson's (MCK) acquisition of RxCrossroads will boost its Specialty Health business.

                          CVS Health (CVS) Beats On Q3 Earnings, Revenues In Line

                          by Zacks Equity Research

                          CVS Health (CVS) witnesses year over year growth in Pharmacy Services segment in Q3.

                            Arpita Dutt headshot

                            Is a CVS Health (CVS) - Aetna (AET) Deal in the Cards?

                            by Arpita Dutt

                            Is an e-commerce company's interest in entering the drug pharmacy space the reason behind CVS Health's (CVS) interest in acquiring Aetna?

                              Rite Aid (RAD) Slumps 14% Since Q2 Loss: What Lies Ahead?

                              by Zacks Equity Research

                              Rite Aid Corporation (RAD), which had quite an eventful journey of late, reported dismal second-quarter fiscal 2018 results last week. However, latest deal with Walgreens should benefit.

                                Can Fred's Strategies Help It Counter Slow Comps & Traffic?

                                by Zacks Equity Research

                                Fred's (FRED) has been struggling with declining store traffic and sluggish comps over the past few quarters. The company has been focusing on cost reduction and internal restructuring.

                                  What FTC's Curtail on RAD Store Purchase Means for Walgreens?

                                  by Zacks Equity Research

                                  Walgreens' (WBA) purchase of lesser number of Rite Aid stores upsets investors. Let's draw an insight from this.

                                    Rite Aid Gets FTC Nod for Sale of Fewer Stores to Walgreens

                                    by Zacks Equity Research

                                    After four amendments, Rite Aid Corp. (RAD) and Walgreens Boots Alliance Inc. (WBA) finally received a nod for the fresh proposal the latter put forward yesterday.

                                      Ryan McQueeney headshot

                                      Why Did Rite Aid (RAD) Stock Crash Today?

                                      by Ryan McQueeney

                                      Shares of Rite Aid (RAD) fell more than 10% on Tuesday after Walgreens Boots (WBA) received government approval to buy fewer Rite Aid stores than had initially been proposed.

                                        Walgreens to Revisit Rite Aid Deal for Antitrust Approval

                                        by Zacks Equity Research

                                        The Federal Trade Commission ("FTC") seems to be getting harsher on drugstore chains Walgreens Boots Alliance Inc. (WBA) and Rite Aid Corp. (RAD), which have been trying to appease the regulatory body since its initial merger pact in 2015.

                                          The Zacks Analyst Blog Highlights: Disney, Kraft Heinz and CVS Health, Intercontinental Exchange and Ventas

                                          by Zacks Equity Research

                                          The Zacks Analyst Blog Highlights: Disney, Kraft Heinz and CVS Health, Intercontinental Exchange and Ventas

                                            Tobacco Stocks in Focus as Cigarette Prices Rise in New York

                                            by Zacks Equity Research

                                            The news of cigarette price hike in New York City and other legislations to reduce the number of smokers have raised concerns of accelerated sales declines for traditional cigarettes.

                                              What You Should Know About Fred's Apart From Dismal Comps

                                              by Zacks Equity Research

                                              Fred's (FRED) is yet to recover from the cancelled Walgreens-Rite Aid merger. The company has also been struggling with declining sales owing to lower comps and store closures.

                                                Investors Are Keeping An Eye On Q2 Earnings

                                                by Zacks Equity Research

                                                Investors Are Keeping An Eye On Q2 Earnings

                                                  Mark Vickery headshot

                                                  Q2 Earnings Rundown: KORS, RL, CVS & More

                                                  by Mark Vickery

                                                  The S&P 500 and Dow both hit new record highs yesterday, but are down marginally in today's pre-market.